Harbour Energy PLC (HBR)
London Exchange · UK · prices in GBX · close of 19 Oct 2026
Key indicators
| Last close | GBX 296.40 |
|---|---|
| 52-week range | 173.81 – 306.56 |
| Return, 1 month / 3 months | +5.6% / +24.9% |
| Return, 1 year / 3 years | +57.4% / +48.1% |
| Trend | Uptrend |
| RSI (14) | 63 |
| Volatility (1 year) | 41.9% |
| Worst drawdown (1 year) | -31.9% |
| Average daily value traded | 1,507.87M GBX |
| Dividend yield | 0.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Harbour Energy is an independent oil and gas company based in London. It explores for and produces oil and natural gas, mainly from fields in the UK North Sea, and also holds interests in projects in other countries. Its customers are the buyers of crude oil and gas, including energy traders and industrial users. The company focuses on operating producing assets and on developing its exploration and development portfolio.
On this site Harbour Energy PLC appears as a stock on the London Exchange (UK), code HBR, with prices in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Harbour Energy PLC (HBR) trades on the London Exchange in UK. It last closed at GBX 296.40 on 19 October 2026.
Its price-based Market X-Ray is 69 out of 100 (a fair price profile), ranking 604 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 57.4% and over the last three months it rose 24.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 82 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.5% | ||
| From 52-week high | -2.6% | ||
| Momentum | 82 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 24.9% | ||
| 6-month return | 9.7% | ||
| 12-month return, skipping the last month | 49.0% | ||
| Stability (higher is calmer) | 41 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 41.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -31.9% | ||
| Liquidity | 98 · Strong | Trades actively. | |
| Average daily value traded | 1,507.87M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 30 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.0% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.0% |
|---|---|
| 1 month | +5.6% |
| 3 months | +24.9% |
| 6 months | +9.7% |
| 1 year | +57.4% |
| 3 years | +48.1% |
| 5 years | +10.5% |
Signals
| 50-day / 200-day average | 267.62 / 250.21 |
|---|---|
| Golden / death cross (60 days) | Golden, 28 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 9.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 13 Aug 2026 | GBP 0.0594 |
| 9 Apr 2026 | GBP 0.0598 |
| 14 Aug 2025 | GBP 0.0973 |
| 10 Apr 2025 | GBP 0.1100 |
| 15 Aug 2024 | GBP 0.1008 |
| 11 Apr 2024 | GBP 0.1044 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.